Tempest Therapeutics Inc (TPST) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.29
• Market Cap: $11.48M
• EPS: $-9.73
• 52-Week High: $12.23
• 52-Week Low: $2.12

Market Sentiment

Tempest Therapeutics Inc currently has a Bullish sentiment score of 0.38.

About Tempest Therapeutics Inc

Tempest Therapeutics Inc. (TPST) is an innovative clinical-stage oncology company based in South San Francisco, California, focusing on the development of proprietary small molecules designed to harness both targeted therapies and immune-mediated mechanisms for the treatment of diverse tumors. With a commitment to advancing cancer therapeutics, Tempest's pipeline includes compounds that aim to improve patient outcomes in challenging oncology indications, positioning the company at the forefro...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Tempest Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TPST pay dividends?

Tempest Therapeutics Inc (TPST) does not currently pay a regular dividend.

What is TPST's market cap?

Tempest Therapeutics Inc (TPST) has a market capitalization of $11.48M with a current stock price of $2.29.